{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-007938","form_type":"8-K","ticker":"BTCY","cik":"0001630113","company_name":"BIOTRICITY INC.","filed_at":"2025-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.240954+00:00","generated_at":"2026-05-26T05:55:38.406814+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biotricity Q3 FY25 revenue $3.6M (+21.7% YoY); net loss down 56.7% to $1.32M","bullets":["Gross margin improved to 76.4% from 72.9% YoY; recurring tech fees 94% of revenue at 81.4% gross profit.","Recurring Technology Fees rose 21.8% YoY to $3.39M; pure SaaS revenue up 22%.","SG&A reduced 20.5% to $2.38M from $3.0M; positive cash flow from operations second consecutive quarter, up 114.5% sequentially.","Net loss per share improved to $0.054 from $0.339 in Q3 FY24."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-007938","json":"https://secwatch.observer/filing/0001493152-25-007938.json","markdown":"https://secwatch.observer/filing/0001493152-25-007938.md","text":"https://secwatch.observer/filing/0001493152-25-007938.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630113/000149315225007938/0001493152-25-007938-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630113/000149315225007938/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T05:55:38.406814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}